Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,353.40
-8.00 (-0.59%)
May 27, 2026, 3:30 PM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 187.18 billion as of May 28, 2026. Its market cap has decreased by -6.21% in one year.
Market Cap
187.18B
Enterprise Value
210.02B
Revenue
31.15B
Ranking
n/a
PE Ratio
29.85
Stock Price
1,353.40
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 187.18B, an increase of 126.31%. That is a compound annual growth rate of 9.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 187.18B | -8.73% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 398.92B |
| Gland Pharma | 381.08B |
| Ajanta Pharma | 377.26B |
| Emcure Pharmaceuticals | 327.10B |
| Wockhardt | 276.27B |
| Piramal Pharma | 231.36B |
| NATCO Pharma | 210.60B |
| Cohance Lifesciences | 166.38B |